Activation of the IL-23/IL-23R pathway facilitates radioresistance in ESCC by triggering Wnt-Notch-mediated G0/1 phase arrest, and that attenuation of this pathway may prove an effective pretreatment for radiation therapy [127]. This evidence concerns the gene IL23A and esophageal squamous cell carcinoma.